<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Paris_Bettencourt_Result skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Paris Bettencourt/Result</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><DIV class="col-md-8"><UL class=" text-left wtf-menu "><LI class="parent main-item"><A href="#">Project  </A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Human_Practices">Human Practices</A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Applied_Design">Applied Design</A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Design">Design</A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Production">Production</A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Active_Testing">Testing </A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Active_Testing">Active Testing</A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Biocompatibility_Testing">Biocompatibility Testing</A></LI></UL><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Model">Modeling</A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Optimization">Optimization</A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Public_Engagement">Public Engagement</A></LI><LI class="parent main-item"><A href="https://2018.igem.org/Team:Paris_Bettencourt/Software">Software  </A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/AMPDesigner_Overview">AMP Designer Overview</A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/AMP_Forest">AMP Forest</A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/AMP_Evolver">AMP Evolver</A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Result">Result</A></LI><LI class="parent main-item"><A href="#">Judging </A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Medal_Criteria">Medal Criteria </A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Results">Key Results</A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/BioBricks">BioBricks</A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/InterLab">InterLab</A></LI><LI class="parent main-item"><A href="#">Team  </A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Members">Members</A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Collaborations">Collaborations</A></LI><LI><A href="https://2018.igem.org/Team:Paris_Bettencourt/Attributions">Attributions</A></LI><LI class="parent main-item"><A href="https://2018.igem.org/Team:Paris_Bettencourt/Lab_Notebook">Lab Notebook</A></LI><LI class="parent main-item"><A href="https://2018.igem.org/Team:Paris_Bettencourt/Acknowledgements">Acknowledgements</A></LI><DIV id="logolist2"><DIV class="sidelogos top5"><DIV id="twitapp"><A class="twitter-timeline" width="250" height="400" data-dnt="true" href="https://twitter.com/iGEM_Paris" data-widget-id="368144501119795201">@iGEM_Paris</A></DIV></DIV></DIV></DIV><DIV class="textbody h1"><H1> RESULTS </H1></DIV><DIV class="textbody h2"><H2>Test AMP Forest on random peptide library</H2></DIV><DIV class="textbody"><P>We tested 47,938 peptides with the AMP Forest 100 model (100 decision trees), and predicted result is highly proportional to the scores measured in experiment, with a correction coefficient ~ 2.1419, and Pearson correlation coefficient ~ 0.982 (Figure 1, where the predicted score is already corrected by the coefficient)</P></DIV><DIV class="textbody span"><B>Figure 1:</B><B>AMP Forest 100 model’s prediction vs experimental measured bacterial survival score on 47938 tested samples.</B></DIV><DIV class="textbody h2"><H2>Limitation of AMP Forest: bias and error analysis at the boundary condition </H2></DIV><DIV class="textbody"><P>First of all, the AMP Forest model describe the sequence - antimicrobial efficiency landscape, according to the peptides detected in the random library. Therefore, it must exist a manifold that could describe the boundary of the model mathematically.</P><P>When the peptide sequences fall inside the manifold, the model could provide an accurate estimation of the antimicrobial efficiency. However, we could consider the possibility of a peptide that is outside the manifold -- where the model loses the power. Here we show a diagram to describe this scenario in a 2D simplification, whereas the real N-mer peptide sequence space is 20*N dimensional.</P></DIV><DIV class="textbody"><P>When we consider the error of predictive model, it is actually obvious that the error is larger and more biased when the score goes further from the 0, i.e. towards to the edge of the model.</P></DIV><DIV class="textbody span"><B>Figure 3:</B><B>Prediction error of AMP Forest 100, where the prediction error is calculated as prediction score - measured score.</B></DIV><DIV class="textbody"><P>Especially, the optimization in the AMP Evolver is making the sequence more and more efficient. The results AMP Forest gives get less and less accurate, and at the end reach the edge of the model, or even jump out of the model due the randomness. Therefore, the outcomes of AMP Designer must be further screened in wet-lab experiment.</P><P>The result from wet-lab experiment could be used to further update, and expand the edge of AMP Forest. As a consequence, the software itself will evolve in this design-build-test cycle.</P></DIV><DIV class="textbody h2"><H2>Positive-cluster modification design principle found on AMP Designer</H2></DIV><DIV class="textbody"><P>First of all, we confirm that the power of AMP Designer by using random mutagenesis as our mutation generator. In the random mutagenesis function, we will first define a random number of the total positions needed to be mutated, then randomly distribute them on the peptide, and finally convert the parent amino acid to a randomly chosen amino acid -- which also means there is small chance (1/20) that nothing changed. </P><P>In only 3 cycles of evolution, we’ve already converge to the same local optimum in all 10 replicates (Figure left), which is consistent to previous reported experience on the difficulty to escape from the local fitness landscape.</P><P>Then we compare the random mutagenesis to a semi-rational method we developed, where we find the positively charged amino acids in the parents and change the charges around them. Although this engineering method is not necessarily to output better AMP all the time (data not shown here), it is an improved mutation generator for AMP Designers, compared to random mutagenesis.</P></DIV><DIV class="textbody"><LI>Positive-cluster modification is easier to jump out of the local optimum and generates more diverse results -- discovered 7 optima in 10 replicates; whereas the results of  random mutagenesis always converge into the same peptides.</LI><LI>The average efficiency score generated by positive-cluster modification (0.4857) is 2.8-fold higher than the random mutagenesis (0.1753).</LI></DIV><DIV class="textbody"><P>Also, as a cost of further exploration, positive-cluster also needs a longer time to converge, when the parameter setup is at the same level.</P></DIV><DIV class="textbody span"><B>Figure 4:</B>Comparison between two mutation generators, random mutagenesis, and positive cluster modification (semi-rational design). Here we show a representative in silico evolutionary experiments, with 10 different replicates (color labeled), either using random or semi-rational design method.
</DIV><DIV class="textbody h2"><H2>Positive-cluster modification principle validation in wet-lab experiment</H2></DIV><DIV class="textbody"><P>Using the positive clustering design principle we found in the AMP Designer, we generated a library containing ~ 12,000 peptides from natural sequences. Using the experimental characterization, we confirmed a log-normal like distribution of the bacterial survival under the present of AMP-protein fusion. Besides, we found out all the top-efficiency AMPs shared a similar pattern -- reduced charges instead of the increase the charge.</P><P>This shows the a trade-off between single AMP efficiency and AMP’s impact on protein expression and folding. According to our experimental data, it seems that the protein expression is a more important parameter to optimize the performance of AMP fused to a scaffold protein. (See details in: )</P></DIV><DIV id="footerdiv"><DIV id="mfooter"><DIV class="footbox"><B>Centre for Research and Interdisciplinarity (CRI)</B>
    Faculty of Medicine Cochin Port-Royal, South wing, 2nd floor
    Paris Descartes University
    24, rue du Faubourg Saint Jacques
    75014 Paris, France<A href="mailto:paris-bettencourt-2018@cri-paris.org">paris-bettencourt-2018@cri-paris.org</A></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>